Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 189483

Naphthalan in the treatment of patients with neurodermitis


Smeh-Skrbin, Ankica; Dobrić, Ivan; Krnjević-Pezić, Gordana; Vržogić, Pero
Naphthalan in the treatment of patients with neurodermitis // Acta Dermatovenerologica Croatica
Zagreb: Grafoplast, 2002. str. 110-110 (predavanje, međunarodna recenzija, sažetak, stručni)


CROSBI ID: 189483 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Naphthalan in the treatment of patients with neurodermitis

Autori
Smeh-Skrbin, Ankica ; Dobrić, Ivan ; Krnjević-Pezić, Gordana ; Vržogić, Pero

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
Acta Dermatovenerologica Croatica / - Zagreb : Grafoplast, 2002, 110-110

Skup
2nd Congress of Croatian Dermatovenerologists in Dermatovenerology, New Highlights in Dermatovenerology

Mjesto i datum
Opatija, Hrvatska, 16.05.2002. - 19.05.2002

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
naphthalan; antiinflammatory and antiproliferative effect

Sažetak
Guided by the results of the study using naphthalan in the treatment of psoriasis (i.e. its antiinflammatory and antiproliferative effect), and stimulated by the satisfactory, months-long remissions in more than 70% of treated patients, we decided to examine the efficacy of naphthalan in the treatment of patients with atopic dermatitis. The study included 15 patients aged >15 with different clinical forms of atopic dermatitis. Naphthalan therapy has been applied for 3 weeks. During this period, the patients were taking baths in tubs containing naphthalan oil (temperature 34-38&ordm ; ; ; C) every day for 12-14 minutes. This is the usual therapy that has been practiced for 12 years in the treatment of patients with psoriasis and rheumatic disease. Besides naphthalan baths, the patients were also applying neutral cream and were administered oral antihistaminics. Evaluation of therapeutic results included clinical evaluation (photographs taken before and after the 3-week therapy) ; SCORAD Index (Severity scoring of atopic dermatitis)-before and after the 3-week therapy ; histologic evaluation ; total IgE ; and laboratory tests After the 3-week naphthalan therapy, all patients experienced improvement in the form of reduction or disappearance of itching and sleeping disorders. The mean SCORAD Index was 71.92 before therapy and 25.66 after the 3-week therapy. Histologic findings showed no signs consistent with atopic dermatitis. Standard laboratory analysis showed no values that would suggest nephrotoxicity, hematotoxicity or hepatotoxicity due to naphthalan oil.

Izvorni jezik
Engleski



POVEZANOST RADA


Profili:

Avatar Url Ivan Dobrić (autor)


Citiraj ovu publikaciju:

Smeh-Skrbin, Ankica; Dobrić, Ivan; Krnjević-Pezić, Gordana; Vržogić, Pero
Naphthalan in the treatment of patients with neurodermitis // Acta Dermatovenerologica Croatica
Zagreb: Grafoplast, 2002. str. 110-110 (predavanje, međunarodna recenzija, sažetak, stručni)
Smeh-Skrbin, A., Dobrić, I., Krnjević-Pezić, G. & Vržogić, P. (2002) Naphthalan in the treatment of patients with neurodermitis. U: Acta Dermatovenerologica Croatica.
@article{article, author = {Smeh-Skrbin, Ankica and Dobri\'{c}, Ivan and Krnjevi\'{c}-Pezi\'{c}, Gordana and Vr\v{z}ogi\'{c}, Pero}, year = {2002}, pages = {110-110}, keywords = {naphthalan, antiinflammatory and antiproliferative effect}, title = {Naphthalan in the treatment of patients with neurodermitis}, keyword = {naphthalan, antiinflammatory and antiproliferative effect}, publisher = {Grafoplast}, publisherplace = {Opatija, Hrvatska} }
@article{article, author = {Smeh-Skrbin, Ankica and Dobri\'{c}, Ivan and Krnjevi\'{c}-Pezi\'{c}, Gordana and Vr\v{z}ogi\'{c}, Pero}, year = {2002}, pages = {110-110}, keywords = {naphthalan, antiinflammatory and antiproliferative effect}, title = {Naphthalan in the treatment of patients with neurodermitis}, keyword = {naphthalan, antiinflammatory and antiproliferative effect}, publisher = {Grafoplast}, publisherplace = {Opatija, Hrvatska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font